l-pam-cured mopc-315 tumor bearers exhibited in vivo immunity against sig- mopc-315 tumor cells , which was sufficiently triggered by the sig- cells to bring about the rejection of a challenge of at least 100-fold the minimal lethal tumor dose of the sig- mopc-315 cells .
C0007634
cells
C0699040
of